Aptamers, synthetic single stranded oligonucleotides are an alternative to antibodies and can be deployed in every application in which you might use an antibody. By replacing antibodies with aptamers it is possible to replace the animal requirement altogether. In addition, the resulting synthetic nucleic acid aptamer will give improved assay consistency, stricter quality control and indefinite supply without ever needing to resort to an animal system. Aptasol, now part of the Aptamer group, are seeking partners interested in adopting or helping to develop their aptamers to replace the use of traditional animal-derived antibodies. For further information please see the flyer.